NAC treatment decreases the expression of the depletion marker PD-1 in CD8+ and CD4+ Teff cells and increases that of the activation markers T-bet and the cytotoxic molecules granzyme B and perforin in the sentinel lymph nodes of BC patients (150). Here, CD8A is linked to breast cancer.